Calton & Associates’s Sempra SRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,786
Closed -$215K 290
2022
Q4
$215K Buy
+2,786
New +$216K 0.08% 247
2022
Q2
Sell
-2,680
Closed -$225K 339
2022
Q1
$225K Buy
+2,680
New +$193K 0.07% 309
2020
Q1
Sell
-3,740
Closed -$283K 374
2019
Q4
$283K Buy
3,740
+118
+3% +$8.66K 0.06% 271
2019
Q3
$267K Buy
+3,622
New +$254K 0.06% 265
2018
Q2
Sell
-10,442
Closed -$581K 381
2018
Q1
$581K Buy
10,442
+7,814
+297% +$422K 0.17% 131
2017
Q4
$139K Buy
+2,628
New +$152K 0.04% 415

Other funds holding SRE

Calton & Associates's SRE Position: Q1 2023 in Review

Calton & Associates sold out of Sempra (SRE) in Q1 2023, closing a stake of 2,786 shares — an estimated $215K sold.

Calton & Associates first reported a position in SRE in Q4 2017 and held it in 6 quarters. The position peaked at $581K in Q1 2018. 981 funds tracked by Wall St. Rank hold SRE as of Q1 2023.

  • Calton & Associates reported no remaining Sempra position as of Q1 2023 after selling out during the quarter.
  • Calton & Associates sold 2,786 Sempra shares in Q1 2023, an estimated $215K.
  • Calton & Associates first reported a position in Sempra in Q4 2017 and held it in 6 quarters.
  • Calton & Associates's Sempra position peaked at $581K in Q1 2018.
  • 981 funds tracked by Wall St. Rank held Sempra as of Q1 2023.

Based on Calton & Associates's 13F filing for Q1 2023, filed 19 Apr 2023.